Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus.

Tagliamento M, Grossi F, Paolino S, Rijavec E, Genova C, Rossi G, Biello F, Maria A.

Immunotherapy. 2019 Jun 3. doi: 10.2217/imt-2019-0025. [Epub ahead of print]

PMID:
31156006
2.

Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.

Ruaro B, Smith V, Sulli A, Pizzorni C, Tardito S, Patané M, Paolino S, Cutolo M.

Front Pharmacol. 2019 Apr 16;10:360. doi: 10.3389/fphar.2019.00360. eCollection 2019.

3.

Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Ruaro B, Soldano S, Smith V, Paolino S, Contini P, Montagna P, Pizzorni C, Casabella A, Tardito S, Sulli A, Cutolo M.

Rheumatol Int. 2019 May 6. doi: 10.1007/s00296-019-04315-7. [Epub ahead of print]

PMID:
31056725
4.

Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study.

Ruaro B, Pizzorni C, Paolino S, Alessandri E, Sulli A.

Front Pharmacol. 2019 Apr 4;10:293. doi: 10.3389/fphar.2019.00293. eCollection 2019.

5.

Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.

Ruaro B, Pizzorni C, Paolino S, Smith V, Ghio M, Casabella A, Alessandri E, Patané M, Sulli A, Cutolo M.

Microvasc Res. 2019 Apr 8;125:103874. doi: 10.1016/j.mvr.2019.04.004. [Epub ahead of print]

PMID:
30974112
6.

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines.

Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. eCollection 2018. Review.

7.

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1.

8.

The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients.

Ruaro B, Sulli A, Smith V, Santiago T, da Silva JAP, Pizzorni C, Paolino S, Alessandri E, Cutolo M.

Clin Exp Rheumatol. 2019 Feb 25. [Epub ahead of print] No abstract available.

PMID:
30873945
9.

Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis.

Cutolo M, Soldano S, Paolino S.

Ann Rheum Dis. 2019 Feb 1. pii: annrheumdis-2019-215063. doi: 10.1136/annrheumdis-2019-215063. [Epub ahead of print] No abstract available.

PMID:
30709814
10.

Systemic lupus erythematosus: state of the art on clinical practice guidelines.

Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.

RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. Review.

11.

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines.

Sulli A, Talarico R, Scirè CA, Avcin T, Castori M, Ferraris A, Frank C, Grunert J, Paolino S, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Malfait F.

RMD Open. 2018 Oct 18;4(Suppl 1):e000790. doi: 10.1136/rmdopen-2018-000790. eCollection 2018.

12.

Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).

Ruaro B, Casabella A, Paolino S, Pizzorni C, Ghio M, Seriolo C, Molfetta L, Odetti P, Smith V, Cutolo M.

Clin Rheumatol. 2018 Nov;37(11):3057-3062. doi: 10.1007/s10067-018-4322-9. Epub 2018 Oct 6.

PMID:
30291470
13.

Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Carbone F, Bonaventura A, Liberale L, Paolino S, Torre F, Dallegri F, Montecucco F, Cutolo M.

Clin Rev Allergy Immunol. 2018 Sep 26. doi: 10.1007/s12016-018-8714-z. [Epub ahead of print] Review.

PMID:
30259381
14.

A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.

Trombetta AC, Soldano S, Contini P, Tomatis V, Ruaro B, Paolino S, Brizzolara R, Montagna P, Sulli A, Pizzorni C, Smith V, Cutolo M.

Respir Res. 2018 Sep 24;19(1):186. doi: 10.1186/s12931-018-0891-z.

15.

Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.

Cutolo M, Soldano S, Montagna P, Trombetta AC, Contini P, Ruaro B, Sulli A, Scabini S, Stratta E, Paolino S, Pizzorni C, Smith V, Brizzolara R.

Arthritis Res Ther. 2018 Jul 27;20(1):157. doi: 10.1186/s13075-018-1652-6.

16.

Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis.

Soldano S PhD, Trombetta AC PhD, Contini P PhD, Tomatis V MD, Ruaro B MD, Brizzolara R PhD, Montagna P PhD, Sulli A MD, Paolino S MD, Pizzorni C MD, Smith V MD, Cutolo M MD.

Ann Rheum Dis. 2018 Dec;77(12):1842-1845. doi: 10.1136/annrheumdis-2018-213648. Epub 2018 Jul 16. No abstract available.

17.

Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients.

Pizzorni C, Cutolo M, Sulli A, Ruaro B, Trombetta AC, Ferrari G, Pesce G, Smith V, Paolino S.

Clin Rheumatol. 2018 Oct;37(10):2723-2729. doi: 10.1007/s10067-018-4211-2. Epub 2018 Jul 13.

PMID:
30006917
18.

Correlation between bone quality and microvascular damage in systemic sclerosis patients.

Ruaro B, Casabella A, Paolino S, Pizzorni C, Alessandri E, Seriolo C, Botticella G, Molfetta L, Odetti P, Smith V, Cutolo M.

Rheumatology (Oxford). 2018 Sep 1;57(9):1548-1554. doi: 10.1093/rheumatology/key130.

PMID:
29788459
19.

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.

Cutolo M, Ruaro B, Montagna P, Brizzolara R, Stratta E, Trombetta AC, Scabini S, Tavilla PP, Parodi A, Corallo C, Giordano N, Paolino S, Pizzorni C, Sulli A, Smith V, Soldano S.

Arthritis Res Ther. 2018 May 2;20(1):77. doi: 10.1186/s13075-018-1577-0.

20.

Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis.

Cutolo M, Trombetta AC, Melsens K, Pizzorni C, Sulli A, Ruaro B, Paolino S, Deschepper E, Smith V.

Microcirculation. 2018 May;25(4):e12447. doi: 10.1111/micc.12447.

PMID:
29527781
21.

Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.

Ruaro B, Sulli A, Smith V, Pizzorni C, Paolino S, Alessandri E, Cutolo M.

Reumatismo. 2017 Dec 21;69(4):147-155. doi: 10.4081/reumatismo.2017.959. Review.

22.

Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study.

Pizzorni C, Sulli A, Paolino S, Ruaro B, Smith V, Trombetta AC, Cutolo M.

J Rheumatol. 2017 Dec;44(12):1941-1942. doi: 10.3899/jrheum.170485. No abstract available.

PMID:
29196550
23.

Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects.

Dall'Ara F, Cutolo M, Andreoli L, Tincani A, Paolino S.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):153-162. Epub 2017 Nov 14. Review.

24.

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?

Paolino S, Cutolo M, Pizzorni C.

Reumatologia. 2017;55(4):189-197. doi: 10.5114/reum.2017.69779. Epub 2017 Aug 31. Review.

25.

Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.

Ruaro B, Paolino S, Pizzorni C, Cutolo M, Sulli A.

Reumatismo. 2017 Sep 21;69(3):134-136. doi: 10.4081/reumatismo.2017.986.

26.

Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients.

Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Alessandri E, Trombetta AC, Alsheyyab J, Cutolo M.

Microvasc Res. 2018 Jan;115:28-33. doi: 10.1016/j.mvr.2017.08.004. Epub 2017 Aug 20.

PMID:
28834709
27.

Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments.

Trombetta AC, Smith V, Gotelli E, Ghio M, Paolino S, Pizzorni C, Vanhaecke A, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2017 Jun 9;12(6):e0179062. doi: 10.1371/journal.pone.0179062. eCollection 2017.

28.

Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2017 Mar 30;12(3):e0175238. doi: 10.1371/journal.pone.0175238. eCollection 2017.

29.

Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.

Sulli A, Ruaro B, Smith V, Paolino S, Pizzorni C, Pesce G, Cutolo M.

Arthritis Res Ther. 2017 Mar 20;19(1):61. doi: 10.1186/s13075-017-1270-8.

30.

Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.

Soldano S, Paolino S, Pizzorni C, Trombetta AC, Montagna P, Brizzolara R, Corallo C, Giordano N, Sulli A, Cutolo M.

Clin Exp Rheumatol. 2017 May-Jun;35(3):484-493. Epub 2017 Jan 27.

PMID:
28134077
31.

Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.

Pizzorni C, Giampetruzzi AR, Mondino C, Facchiano A, Abeni D, Paolino S, Ruaro B, Smith V, Sulli A, Cutolo M.

Microvasc Res. 2017 May;111:20-24. doi: 10.1016/j.mvr.2016.12.003. Epub 2016 Dec 16.

PMID:
27989404
32.

Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2016 Nov 15;11(11):e0166433. doi: 10.1371/journal.pone.0166433. eCollection 2016. Erratum in: PLoS One. 2017 Mar 30;12 (3):e0175238.

33.

Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.

Trombetta AC, Pizzorni C, Ruaro B, Paolino S, Sulli A, Smith V, Cutolo M.

J Rheumatol. 2016 Nov;43(11):2033-2041. Epub 2016 Oct 1.

34.

Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology.

Pizzorni C, Sulli A, Smith V, Ruaro B, Trombetta AC, Cutolo M, Paolino S.

Clin Rheumatol. 2017 Jul;36(7):1637-1642. doi: 10.1007/s10067-016-3442-3. Epub 2016 Oct 8.

PMID:
27722973
35.

The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up.

Drago F, De Col E, Agnoletti AF, Schiavetti I, Savarino V, Rebora A, Paolino S, Cozzani E, Parodi A.

J Am Acad Dermatol. 2016 Sep;75(3):e113-e115. doi: 10.1016/j.jaad.2016.01.059. No abstract available.

PMID:
27543234
36.

Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy.

Vera L, Gay S, Campomenosi C, Paolino S, Pera G, Monti E, Mortara L, Seriolo B, Giusti M.

Endokrynol Pol. 2016;67(4):350-8. doi: 10.5603/EP.a2016.0046. Epub 2016 Jul 8.

37.

Systemic sclerosis: markers and targeted treatments.

Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V.

Acta Reumatol Port. 2016 Jan-Mar;41(1):18-25. Review.

38.

Capillaroscopy 2016: new perspectives in systemic sclerosis.

Pizzorni C, Sulli A, Smith V, Lladó A, Paolino S, Cutolo M, Ruaro B.

Acta Reumatol Port. 2016 Jan-Mar;41(1):8-14. Review.

39.

Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Smith V, Thevissen K, Trombetta AC, Pizzorni C, Ruaro B, Piette Y, Paolino S, De Keyser F, Sulli A, Melsens K, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review.

PMID:
27086648
40.

Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages.

Cutolo M, Paolino S, Pizzorni C, Sulli A, Seriolo B, Cimmino MA, Montagna P, Soldano S, Contini P, Brizzolara R.

Clin Exp Rheumatol. 2016 May-Jun;34(3):500-6. Epub 2016 Mar 3.

PMID:
26940199
41.

Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients.

Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Cutolo M.

Microvasc Res. 2016 May;105:119-24. doi: 10.1016/j.mvr.2016.02.007. Epub 2016 Feb 18.

PMID:
26907637
42.

Etiopathogenesis of rosacea: a prospective study with a three-year follow-up.

Agnoletti AF, DE Col E, Parodi A, Schiavetti I, Savarino V, Rebora A, Paolino S, Cozzani E, Drago F.

G Ital Dermatol Venereol. 2017 Oct;152(5):418-423. doi: 10.23736/S0392-0488.16.05315-3. Epub 2016 Feb 18.

PMID:
26889725
43.

Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern.

Trombetta AC, Smith V, Pizzorni C, Meroni M, Paolino S, Cariti C, Ruaro B, Sulli A, Cutolo M.

J Rheumatol. 2016 Mar;43(3):599-606. doi: 10.3899/jrheum.150900. Epub 2016 Feb 1.

PMID:
26834221
44.

CTLA-4 blockade in the treatment of rheumatoid arthritis: an update.

Cutolo M, Sulli A, Paolino S, Pizzorni C.

Expert Rev Clin Immunol. 2016;12(4):417-25. doi: 10.1586/1744666X.2016.1133295. Epub 2016 Jan 22. Review.

PMID:
26679631
45.

A method for counting monosodium urate crystals in synovial fluid.

Montagna P, Brizzolara R, Ferrone C, Cutolo M, Paolino S, Cimmino MA.

Reumatismo. 2015 Jun 30;67(1):29-32. doi: 10.4081/reumatismo.2015.827.

46.

Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients.

Ruaro B, Sulli A, Smith V, Paolino S, Pizzorni C, Cutolo M.

Microvasc Res. 2015 Sep;101:82-5. doi: 10.1016/j.mvr.2015.06.009. Epub 2015 Jun 30.

PMID:
26142117
47.

CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.

Cutolo M, Montagna P, Soldano S, Contini P, Paolino S, Pizzorni C, Seriolo B, Sulli A, Brizzolara R.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):250-4. Epub 2015 Apr 9.

PMID:
25896473
48.

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.

Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S1. doi: 10.1186/ar4685. Review.

49.

Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases.

Cutolo M, Paolino S, Pizzorni C.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):839-47. Epub 2014 Dec 9. Review.

PMID:
25496746
50.

Vitamin D, steroid hormones, and autoimmunity.

Cutolo M, Paolino S, Sulli A, Smith V, Pizzorni C, Seriolo B.

Ann N Y Acad Sci. 2014 May;1317:39-46. doi: 10.1111/nyas.12432. Epub 2014 Apr 16.

PMID:
24739090

Supplemental Content

Loading ...
Support Center